In a remarkable advancement in AI-driven medical technology, a Claude model has autonomously chosen a gene therapy and performed brain surgery on an epileptic mouse, marking a first in the field. The AI agent was responsible for selecting the appropriate drug, identifying the target area in the brain, and determining the precise injection coordinates, all without human intervention.
Lead researcher Ocana-Santero noted that this achievement underscores the potential of AI to make independent medical decisions. However, the operation faced a challenge when a calibration error occurred mid-surgery, prompting the AI to halt the procedure, demonstrating the importance of oversight in AI applications in sensitive medical contexts.
This groundbreaking event raises important questions about the future role of AI in healthcare, particularly in surgical procedures, and the ethical implications of autonomous decision-making in medical treatments.
Compiled automatically by the Tech AI Newsdesk from public AI-news sources and summarised in our own words.
